The present study found that the use of human albumin was connected with increased risk-adjusted mortality during hospitalization, as well as prolonged hospital and ICU stays, in patients diagnosed with Heart Failure (HF) and serum albumin levels ≤ 2.9 g/dL, compared to individuals who did not receive albumin. Here, ALB is linked to hydrops fetalis.